Regulations.gov document
Supplement to October 17,2016 CP Submitted by Baker & Hostetler, LLP (Salix…
Other · FDA-2016-P-3418 · posted Mar 14, 2017
Key facts
| Document ID | FDA-2016-P-3418-0119 |
|---|---|
| Title | Supplement to October 17,2016 CP Submitted by Baker & Hostetler, LLP (Salix Pharmaceuticals, Inc.) Redacted and Non-Redacted Versions |
| Document type | Other |
| Subtype | Supplement (SUP) |
| Agency | FDA |
| Docket | FDA-2016-P-3418 |
| Posted | Mar 14, 2017 |
| Comment period opens | Mar 14, 2017 |
At a glance
- None Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: